Rank 79 • AI & Clinical Intelligence
Anumana
Develops AI-driven electrocardiogram algorithms to detect hidden cardiovascular diseases and guide therapeutic decisions.
Visit website- Signal Score
- 83.4
- Total raised
- $35M
- Stage
- Series B
- Founded
- 2021
- Headquarters
- Cambridge, USA
- Region
- North America
Their signal
Co-founded as a joint venture with the Mayo Clinic, Anumana excels in developing FDA-cleared ECG-AI algorithms that flag early-stage cardiac dysfunction long before physical symptoms appear.
Signal Score 83.4editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in AI & Clinical Intelligence
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.